Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at IHG's multiple
$74.94167.3% above market
2.30 ACAD EPS (TTM)×32.58x IHG P/E=$74.94
Market $28.04Implied $74.94
IHG · current priceP/E 32.58x
$159.95Latest market snapshot
Implied fair value · at ACAD's multiple
$59.8562.6% below market
4.91 IHG EPS (TTM)×12.19x ACAD P/E=$59.85
Market $159.95Implied $59.85